FRAMINGHAM, Mass. and SYDNEY, July 29 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that its Annual Meeting will be held at The Westin Sydney, 1 Martin Place, Sydney at 7:00 pm US Eastern today, July 29 (9:00 am Sydney time on July 30, 2009).
The Annual Meeting will be webcast and may be viewed at the Company's website (www.heartware.com) by selecting "HeartWare International Annual General Meeting - Webcast" under the section titled Corporate Presentations (on the HOME page).
About HeartWare International, Inc.
HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or Left Ventricular Assist Devices (LVADs), to treat patients suffering from advanced heart failure. The HeartWare((R)) Ventricular Assist System features the HVAD((TM)) pump, the only full-output pump designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has completed an international clinical trial for the device involving five investigational centres in Europe and Australia. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication.
For further information: US Investor Relations Matt Clawson Partner Allen & Caron Inc Email: email@example.com Tel: +1 949 474 4300
|SOURCE HeartWare International, Inc.|
Copyright©2009 PR Newswire.
All rights reserved